Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy

Ítems similars

• Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy
  per: Sam Gandy, et al.
  Publicat: (2023-11-01)
• Oxidative stress: culprit or consequence in Alzheimer’s amyloidopathy
  per: Chanchal Sharma, et al.
  Publicat: (2023-01-01)
• The Role of Vitamin D in Alzheimer’s Disease: A Transcriptional Regulator of Amyloidopathy and Gliopathy
  per: Jiseung Kang, et al.
  Publicat: (2022-07-01)
• Dual role of miR-155 and exosomal miR-155 in tumor angiogenesis: implications for cancer progression and therapy
  per: Qusay Mohammed Hussain, et al.
  Publicat: (2025-05-01)
• Microglia specific deletion of miR-155 in Alzheimer’s disease mouse models reduces amyloid-β pathology but causes hyperexcitability and seizures
  per: Macarena S. Aloi, et al.
  Publicat: (2023-03-01)